If successful, the new stem cell delivery system will revolutionize treatment of osteoarthritis and other chronic health problems caused by lost or damaged cartilage. Nearly half of the adult population will have some kind of arthritis by the year 2020, according to health care experts.
“When we use stem cells to rebuild damaged cartilage, such as in an injured knee, we need a scaffolding to hold the stem cells in place as they do their work, much like a scaffolding is required for construction of a new building,,” said Brian Johnstone, Ph.D., Research Director for the Department of Orthopaedics and Rehabilitation. However, scaffolding can get in the way of full recovery if it remains after the stem cells have become fully formed cartilage cells. That’s why Johnstone and his team have developed a “bioresponsive” scaffold that is dismantled by the cells as they form the new cartilage. The scaffold is dismantled at just the right pace, which is critical.
“Timing is very important,” Johnstone says. “You don’t want it to happen too quickly or drag out so long that it inhibits the regeneration process. We’ve discovered a way for the cell’s own enzymes to take apart the scaffolding at just the right speed.” Johnstone and his research team will use the NFL grant to begin testing the new scaffolding in mice. If successful, this could lead to a similar application in humans.